IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 50 filers reported holding IMMUNOCORE HLDGS PLC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $732,800 | +20.5% | 14,822 | +14.5% | 0.02% | +20.0% |
| Q3 2022 | $608,000 | +22.1% | 12,944 | -6.6% | 0.02% | +42.9% |
| Q2 2022 | $498,000 | +23.9% | 13,858 | +2.4% | 0.01% | +75.0% |
| Q1 2022 | $402,000 | -12.6% | 13,534 | +0.4% | 0.01% | -11.1% |
| Q4 2021 | $460,000 | -23.7% | 13,485 | -17.2% | 0.01% | -18.2% |
| Q3 2021 | $603,000 | +30.0% | 16,292 | +23.8% | 0.01% | +37.5% |
| Q2 2021 | $464,000 | -18.7% | 13,162 | -0.4% | 0.01% | -20.0% |
| Q1 2021 | $571,000 | – | 13,211 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $34,592,303 | 27.53% |
| RTW INVESTMENTS, LP | 6,029,633 | $361,536,795 | 6.88% |
| Paradigm Biocapital Advisors LP | 1,270,124 | $76,156,635 | 5.88% |
| Rock Springs Capital Management LP | 3,028,410 | $181,583,464 | 4.32% |
| Logos Global Management LP | 500,000 | $29,980,000 | 4.08% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $24,319,776 | 3.58% |
| GREAT POINT PARTNERS LLC | 297,082 | $17,813,037 | 3.49% |
| Eschler Asset Management LLP | 34,000 | $2,038,640 | 2.89% |
| COWEN AND COMPANY, LLC | 460,036 | $27,583,758 | 2.29% |
| HighVista Strategies LLC | 44,094 | $2,643,876 | 1.21% |